Midline Catheter Management

Guideline-Based Recommendations

The Centers for Disease Control and Prevention (CDC) recommends that midline catheters should not be routinely replaced to prevent infection, with a Category IB recommendation 1, 2
The CDC explicitly states that midline catheters should not be routinely replaced to reduce the risk of infection, with no predetermined maximum dwell time specified in guidelines 1, 2
Midline catheters should be replaced only when there is a specific clinical indication, such as signs of phlebitis, evidence of infection, catheter malfunction, or infiltration/extravasation 1, 3, 4

The median dwell time for midline catheters is 7 days, with documented safe use up to 49 days in prospective studies 5

The infection risk with midline catheters does not increase with duration of catheterization 5
The bloodstream infection rate for midline catheters is 0.8 per 1,000 catheter-days 5
No specific risk factors, including duration of catheterization, were associated with infection in prospective studies 5

The CDC recommends evaluating the catheter insertion site daily by palpation through the dressing to detect tenderness, visual inspection if using a transparent dressing, and removing opaque dressings only if clinical signs of infection develop 1

The CDC recommends not applying arbitrary time limits for midline removal based solely on duration, as this is not supported by evidence 1, 5
The CDC recommends not routinely applying prophylactic topical antimicrobials to the insertion site 1
The American College of Physicians recommends periodically reassessing whether the catheter is still needed, as the main risk factor for catheter-associated infections is duration 6

Midline catheters should be considered when IV therapy duration will likely exceed 6 days 2

The American College of Physicians recommends midline catheters for patients requiring IV therapy duration exceeding 6 days, particularly for peripherally compatible infusates, and when peripheral venous access is difficult or unavailable 7, 8
The Centers for Disease Control and Prevention suggests midline catheters as an alternative to short peripheral catheters to reduce phlebitis rates 9
The American College of Physicians recommends against using midline catheters for vesicant or irritant chemotherapy administration, which requires central access 8
The Society of Critical Care Medicine recommends against using midline catheters in hemodynamically unstable patients requiring vasopressors, as central access is preferred 8

The Centers for Disease Control and Prevention reports a catheter-related bloodstream infection (CRBSI) rate of 0.8 per 1,000 catheter-days 9
The American College of Physicians reports a phlebitis rate of 0.3%, which is significantly lower than short peripheral catheters 9

The Society of Critical Care Medicine recommends using ultrasound guidance for visualization and optimal vein selection during midline catheter insertion 10
The American College of Physicians recommends selecting upper extremity sites, such as the basilic or brachial veins, for midline catheter placement 7
The Centers for Disease Control and Prevention recommends applying maximal sterile barrier precautions during insertion 7
The American College of Physicians recommends evaluating the insertion site daily by palpation through dressing for tenderness 7
The Society of Critical Care Medicine recommends removing the midline catheter immediately if signs of phlebitis, infection, or malfunction develop 7